From Peptides to Aliskiren: The Evolution of Direct Renin Inhibitors in Hypertension Therapy.
- DOI
- 10.2174/0113895575447246260730050136
- Published
- 2026 Aug 3
- Container
- Mini reviews in medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0113895575447246260730050136,
title = {From Peptides to Aliskiren: The Evolution of Direct Renin Inhibitors in Hypertension Therapy.},
author = {Saha P and Bhattacharya S and Adon T and Viswanatha GL and Hani U and Yogish Kumar HY},
year = {2026},
journal = {Mini reviews in medicinal chemistry},
doi = {10.2174/0113895575447246260730050136},
url = {https://doi.org/10.2174/0113895575447246260730050136}
}RIS
TY - JOUR TI - From Peptides to Aliskiren: The Evolution of Direct Renin Inhibitors in Hypertension Therapy. AU - Saha P AU - Bhattacharya S AU - Adon T AU - Viswanatha GL AU - Hani U AU - Yogish Kumar HY PY - 2026 JO - Mini reviews in medicinal chemistry DO - 10.2174/0113895575447246260730050136 UR - https://doi.org/10.2174/0113895575447246260730050136 ER -
APA
P, S., S, B., T, A., GL, V., U, H., & HY, Y. K. (2026). From Peptides to Aliskiren: The Evolution of Direct Renin Inhibitors in Hypertension Therapy.. Mini reviews in medicinal chemistry. https://doi.org/10.2174/0113895575447246260730050136
Source records
- pubmed · retrieved 2026-09-27T11:26:33.042Z